Astellas Pharma has acquired Dynogen Pharmaceuticals NC-based research facility. The research facility specializes in state-of-the-art preclinical studies for genitourinary disorders. Financial details were not disclosed. “We’ve built an impressive clinical and preclinical pipeline through our unique understanding of the neuroscience underlying gastrointestinal and genitourinary disorders, leveraging that knowledge to generate strong intellectual property and utilizing that inte...